CJC-1295 in Thailand: Growth Hormone & Body Composition Therapy
CJC-1295 is a synthetic GHRH analogue that stimulates sustained growth hormone release through pituitary GHRH receptor binding, supporting muscle recovery, fat metabolism, and body composition improvement. It is most often prescribed alongside Ipamorelin in physician-supervised growth hormone optimization protocols.
Doctor-prescribed CJC-1295 in Thailand is available at Peptides Thailand under physician supervision, with clinical-grade, COA-verified subcutaneous formulation. It is most frequently combined with Ipamorelin in structured growth hormone optimization protocols for body composition, fat metabolism, and recovery.
How CJC-1295 Works
CJC-1295 has been studied for its potential effects on growth hormone release through GHRH receptor binding in the anterior pituitary gland. Its modified structure includes Drug Affinity Complex (DAC) technology that extends its half-life. Research has examined its potential effects on growth hormone and IGF-1 levels.
Medical Review Status
Last reviewed: June 2026 | Next review: December 2026
Written by Dr. Michael Ackland · Medically reviewed by Dr. Ploy Pitayanon, MD, licensed by the Medical Council of Thailand
At a Glance
Peptide
CJC-1295
Category
Injectable Peptide
Dosage
1000-2000mcg per week
Frequency
2-3 times per week
Administration
Subcutaneous injection
Potential Benefits
- · Studied for potential effects on growth hormone secretion
- · Investigated for potential effects on lean body composition
- · Studied for potential effects on fat oxidation and metabolism
Quality Matters
Why we use Clinical-Grade only
Certificate of Analysis
Every peptide we dispense comes with a third-party COA confirming purity and potency, never grey-market sourced.
Compounded in Thailand
Manufactured in Thai FDA-licensed compounding laboratories operating under GMP standards.
Physician-prescribed only
No dispensing without a prescription. Every protocol begins with a licensed physician consultation and clinical assessment.
Medical Disclaimer
The information on this page is intended for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Any therapies, consultations, or prescriptions are provided only following assessment by a licensed physician and where clinically appropriate. Individual results may vary and no specific outcomes are guaranteed. Certain compounds discussed may not be approved medicines registered with the Thai FDA for specific therapeutic indications. Nothing here should be interpreted as a recommendation to self diagnose, self treat, or replace consultation with a qualified healthcare professional.
Doctor's Note
Dr. Ploy Pitayanon, MD, Medical Lead
CJC-1295 requires careful medical supervision and individualized dosing. Our clinics in Chiang Mai and Phuket provide comprehensive assessment, monitoring, and ongoing support to ensure safe and effective treatment outcomes.
Potential Benefits
Studied for potential effects on growth hormone secretion
Investigated for potential effects on lean body composition
Studied for potential effects on fat oxidation and metabolism
Investigated for potential effects on recovery
Studied for potential effects on sleep quality
May show potential effects on skin health in some research
Investigated for potential effects on energy and vitality
Studied for potential effects on immune function
Investigated for potential effects on exercise performance
Studied for potential effects on bone density maintenance
Speak with a physician
Interested in CJC-1295?
All protocols require a physician assessment before any prescription is issued. Book a free video consultation with an MCT-licensed doctor.
Treatment Protocol
Dosage
1000-2000mcg per week
Frequency
2-3 times per week
Duration
8-12 weeks per cycle
Administration
Subcutaneous injection
Safety guide
CJC-1295 Side Effects & Safety
Frequency, contraindications, and who is a good candidate
Recent CJC-1295 Research
Pulsatile Secretion of GH Persists During Continuous Stimulation by CJC-1295
Demonstrated CJC-1295 maintains physiological pulsatile growth hormone secretion during continuous GHRH receptor stimulation, supporting its use for natural GH augmentation (J Clin Endocrinol Metab, 2006).
View on PubMedOnce-daily Administration of CJC-1295, a Long-acting GHRH Analog, in Children with GH Deficiency
Showed once-daily CJC-1295 effectively stimulated GH secretion and improved growth outcomes in children with GH deficiency, confirming its prolonged pharmacokinetic profile (Am J Physiol Endocrinol Metab, 2006).
View on PubMedConfirmation of CJC-1295 in Equine Plasma Samples by LC-MS/MS for Doping Control
Confirmed CJC-1295 is detectable and pharmacologically active in plasma, demonstrating its established role as a potent GH-releasing hormone analogue with prolonged biological activity (Drug Test Anal, 2019).
View on PubMedRelated Peptides
Related Conditions
Prefer to message first?
Chat with our team on WhatsApp. We typically reply within minutes.
Chat about CJC-1295